Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
FABRAZYME (AUTHORIZED: FABRY DISEASE
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
||
|
WHO-VATC |
QA16AB04
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
||
|
FDA ORPHAN DRUG |
15286
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
||
|
NCI_THESAURUS |
C29726
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
||
|
NDF-RT |
N0000175822
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
||
|
WHO-ATC |
A16AB04
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
||
|
NDF-RT |
N0000167711
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
LL-45
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
PRIMARY | |||
|
SUB12457MIG
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
PRIMARY | |||
|
Agalsidase Beta
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
PRIMARY | |||
|
RZD65TSM9U
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
PRIMARY | |||
|
DB00103
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
PRIMARY | |||
|
5018
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
PRIMARY | |||
|
338817
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
PRIMARY | RxNorm | ||
|
100000089283
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
PRIMARY | |||
|
9025-35-8
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
ALTERNATIVE | |||
|
8119
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
PRIMARY | |||
|
CHEMBL2108888
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
PRIMARY | |||
|
104138-64-9
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
GENERIC (FAMILY) | |||
|
C74210
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
PRIMARY | |||
|
C459420
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
PRIMARY | |||
|
RZD65TSM9U
Created by
admin on Mon Mar 31 18:46:20 GMT 2025 , Edited by admin on Mon Mar 31 18:46:20 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
